Evidence map›Paper›PMID 22300697›Full record

ArticleJournal of the American College of Cardiology2012

In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes.

Karen C Briley-Saebo, Tuyen Hoang Nguyen, Alexander M Saeboe, Young-Seok Cho, Sung Kee Ryu, Eugenia R Volkova, Eugenia Volkava, Stephen Dickson, Gregor Leibundgut, Philipp Wiesner and 8 more

Erratum issuedAbstract readComparative Study
In one paragraph

Article in Journal of the American College of Cardiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Advanced Functional Nanomaterials for Theranostics.Advanced functional materials · 2017
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Zebrafish models of dyslipidemia: relevance to atherosclerosis and angiogenesis.Translational research : the journal of laboratory and clinical medicine · 2014
    Review
  20. Review
4 · The record

Corrections and comments

  • Erratum issued
    Volkava, Eugenia [corrected to Volkova, Eugenia R]; Weisner, Philipp [corrected to Wiesner, Philipp]
5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Karen C Briley-SaeboImaging Science Laboratory, Department of Radiology, Mount Sinai School of Medicine, New York, NY 10029, USA. saebo@mountsinai.org
Tuyen Hoang Nguyen
Alexander M Saeboe
Young-Seok Cho
Sung Kee Ryu
Eugenia R Volkova
Eugenia Volkava
Stephen Dickson
Gregor Leibundgut
Philipp Wiesner
Philipp Weisner
Simone Green
Florence Casanada
Yury I Miller
Walter Shaw
Joseph L Witztum
Zahi A Fayad
Sotirios Tsimikas
University of California San Diego · USIcahn School of Medicine at Mount Sinai · USAvanti Polar Lipids (United States) · USCardiovascular Institute of the South · USEulji University · KRSeoul National University Hospital · KR

Funding

Development of New Molecular Probes for Diagnostic Imaging of AtherosclerosisR21HL091399 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BRILEY-SAEBO, KAREN CATHERIN · 2009 to 2010
$466k
NHLBI NIH HHS R21 HL091399
6 · The paper itself

Abstract

objectivesThis study sought to evaluate the in vivo magnetic resonance imaging (MRI) efficacy of manganese [Mn(II)] molecular imaging probes targeted to oxidation-specific epitopes (OSE).

backgroundOSE are critical in the initiation, progression, and destabilization of atherosclerotic plaques. Gadolinium [Gd(III)]-based MRI agents can be associated with systemic toxicity. Mn is an endogenous, biocompatible, paramagnetic metal ion that has poor MR efficacy when chelated, but strong efficacy when released within cells.

methodsMultimodal Mn micelles were generated to contain rhodamine for confocal microscopy and conjugated with either the murine monoclonal IgG antibody MDA2 targeted to malondialdehyde (MDA)-lysine epitopes or the human single-chain Fv antibody fragment IK17 targeted to MDA-like epitopes ("targeted micelles"). Micelle formulations were characterized in vitro and in vivo, and their MR efficacy (9.4-T) evaluated in apolipoprotein-deficient (apoE(-/-)) and low-density lipoprotein receptor negative (LDLR(-/-)) mice (0.05 mmol Mn/kg dose) (total of 120 mice for all experiments). In vivo competitive inhibition studies were performed to evaluate target specificity. Untargeted, MDA2-Gd, and IK17-Gd micelles (0.075 mmol Gd/kg) were included as controls.

resultsIn vitro studies demonstrated that targeted Mn micelles accumulate in macrophages when pre-exposed to MDA-LDL with ∼10× increase in longitudinal relativity. Following intravenous injection, strong MR signal enhancement was observed 48 to 72 h after administration of targeted Mn micelles, with colocalization within intraplaque macrophages. Co-injection of free MDA2 with the MDA2-Mn micelles resulted in full suppression of MR signal in the arterial wall, confirming target specificity. Similar MR efficacy was noted in apoE(-/-) and LDLR(-/-) mice with aortic atherosclerosis. No significant differences in MR efficacy were noted between targeted Mn and Gd micelles.

conclusionsThis study demonstrates that biocompatible multimodal Mn-based molecular imaging probes detect OSE within atherosclerotic plaques and may facilitate clinical translation of noninvasive imaging of human atherosclerosis.

Indexed as

Biocompatible MaterialsManganeseAnimalsDisease Models, AnimalEpitopesLipoproteinsMagnetic Resonance SpectroscopyMiceMice, KnockoutMicellesOxidation-ReductionPlaque, AtheroscleroticReproducibility of ResultsBiocompatible MaterialsEpitopesLipoproteinsManganeseMicelles

Identifiers

PMID22300697
PMCPMC3333483
OpenAlexW1966997695

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.